These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30978727)

  • 21. Hepcidin deficiency undermines bone load-bearing capacity through inducing iron overload.
    Sun L; Guo W; Yin C; Zhang S; Qu G; Hou Y; Rong H; Ji H; Liu S
    Gene; 2014 Jun; 543(1):161-5. PubMed ID: 24561287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis.
    Chen B; Li GF; Shen Y; Huang XI; Xu YJ
    Exp Ther Med; 2015 Jul; 10(1):7-11. PubMed ID: 26170904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen replacement therapy: indications and complications.
    Judd HL; Meldrum DR; Deftos LJ; Henderson BE
    Ann Intern Med; 1983 Feb; 98(2):195-205. PubMed ID: 6824255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietic regulators of iron metabolism.
    Ganz T
    Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Iron deficiency and overload. Implications in oxidative stress and cardiovascular health].
    Toxqui L; De Piero A; Courtois V; Bastida S; Sánchez-Muniz FJ; Vaquero MP
    Nutr Hosp; 2010; 25(3):350-65. PubMed ID: 20593115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron metabolism: State of the art.
    Daher R; Karim Z
    Transfus Clin Biol; 2017 Sep; 24(3):115-119. PubMed ID: 28694024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways for the regulation of body iron homeostasis in response to experimental iron overload.
    Theurl I; Ludwiczek S; Eller P; Seifert M; Artner E; Brunner P; Weiss G
    J Hepatol; 2005 Oct; 43(4):711-9. PubMed ID: 16083989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of hepcidin and iron-overload disease.
    Lee PL; Beutler E
    Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated Levels of Estrogen Suppress Hepcidin Synthesis and Enhance Serum Iron Availability in Premenopausal Women.
    Bajbouj K; Shafarin J; Allam H; Madkour M; Awadallah S; El-Serafy A; Sandeep D; Hamad M
    Exp Clin Endocrinol Diabetes; 2018 Jul; 126(7):453-459. PubMed ID: 29396964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of alcohol on the regulation of iron metabolism].
    Cylwik B; Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2008 Sep; 25(147):273-5. PubMed ID: 19112848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in understanding iron metabolism and its crosstalk with erythropoiesis.
    Camaschella C; Pagani A
    Br J Haematol; 2018 Aug; 182(4):481-494. PubMed ID: 29938779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepcidin is an endogenous protective factor for osteoporosis by reducing iron levels.
    Zhang P; Wang S; Wang L; Shan BC; Zhang H; Yang F; Zhou ZQ; Wang X; Yuan Y; Xu YJ
    J Mol Endocrinol; 2018 May; 60(4):297-306. PubMed ID: 29563156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
    Arnold J; Sangwaiya A; Bhatkal B; Arnold A
    Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy: current controversies.
    Davison S; Davis SR
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):249-61. PubMed ID: 12608928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron: effect of overload and deficiency.
    Hider RC; Kong X
    Met Ions Life Sci; 2013; 13():229-94. PubMed ID: 24470094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen(s) and analogs as a non-immunogenic endogenous ligand in targeted drug/DNA delivery.
    Rai S; Paliwal R; Vaidya B; Gupta PN; Mahor S; Khatri K; Goyal AK; Rawat A; Vyas SP
    Curr Med Chem; 2007; 14(19):2095-109. PubMed ID: 17691950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone metabolism and oxidative stress in postmenopausal rats with iron overload.
    Isomura H; Fujie K; Shibata K; Inoue N; Iizuka T; Takebe G; Takahashi K; Nishihira J; Izumi H; Sakamoto W
    Toxicology; 2004 Apr; 197(2):93-100. PubMed ID: 15003320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice.
    Mueller SO; Korach KS
    Curr Opin Pharmacol; 2001 Dec; 1(6):613-9. PubMed ID: 11757817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.